C OSBORNE to Biopsy
This is a "connection" page, showing publications C OSBORNE has written about Biopsy.
Connection Strength
0.069
-
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A. 2009 Aug 18; 106(33):13820-5.
Score: 0.030
-
Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients. J Clin Oncol. 1992 Feb; 10(2):304-10.
Score: 0.018
-
Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. J Clin Oncol. 2005 Apr 10; 23(11):2469-76.
Score: 0.011
-
Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J Clin Oncol. 1992 Mar; 10(3):428-32.
Score: 0.004
-
An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute. Cancer. 1983 Aug 01; 52(3):393-8.
Score: 0.002
-
Multiple estrogen receptor assays in human breast cancer. Cancer Res. 1983 Jan; 43(1):413-6.
Score: 0.002
-
Histologic progression in non-Hodgkin's lymphoma. Blood. 1982 Feb; 59(2):258-64.
Score: 0.002